Arousal effects of orexin-A correlate with GLU release from the locus coeruleus in rats

Peptides

Volumn 23, Issue 9, 2002, Pages 1673-1681

  Kodama, Tohru ^a   Kimura, Mayumi ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CSF; Diurnal variation; Glutamate (GLU); Hypocretin; Locus coeruleus; Microdialysis; Orexin A

Indexed keywords

GLUTAMIC ACID; OREXIN; OREXIN A;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG MECHANISM; INJECTION; LIGHT DARK CYCLE; LOCUS CERULEUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WAKEFULNESS;

ANIMALS; AROUSAL; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; GLUTAMIC ACID; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGHT; LOCUS COERULEUS; MALE; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SLEEP; TIME FACTORS;

EID: 0036710538     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00109-2     Document Type: Article

References (43)

1. Bourgin P., Huitron-Resendiz S., Spier A.D., Fabre V., Morte B., Criado J.R.et al. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci. 20:2000;7760-7765.
2. Brown R.E., Sergeeva O., Eriksson K.S., Haas H.L. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neurophar. Acol. 40:2001;457-459.
3. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammelli T., Lee C.et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
4. Date Y., Ueta Y., Yamashita H., Yamauchi H., Matsukura S., Kangawa K.et al. Orexins, orexigenic hypothalamic peptides, intact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U.S.A. 96:1999;748-753.
5. de Lecea L., Kilduff T., Peyron C., Gao X.-B., Foye P.E., Danielson P.E.et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 95:1998;322-327.
6. Estabrooke I.V., McCarthy M.T., Ko E., Chou T.C., Chemelli R.M., Yanagisawa M.et al. Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21:2001;1656-1662.
7. Fujiki N., Yoshida Y., Ripley B., Honda K., Mingot E., Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 h and in response to food deprivation. Neuroreport. 12:2001;993-997.
8. Fung S.J., Barnes C.D. Membrane excitability changes in hindlimb motoneurons induced by stimulation of the locus coeruleus in cats. Brain Res. 402:1987;230-242.
9. Gao X.-B., Obrietan K., Kilduff T.S., Belousov A. Presynaptic and postsynaptic actions and modulation of neuroendcrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 18:1998;7962-7971.
10. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S.et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10911-10916.
11. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M.et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 30:2001;345-354.
12. Harms P.G., Ojeda S.R. A rapid and simple procedure for chronic cannulation of the rat jugular vein. J. Appl. Physiol. 36:1974;391-392.
13. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S.et al. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 415:1999;145-159.
14. Huang Z.L., Qu W.M., Li W.D., Mochizuki T., Eguchi N., Watanabe T.et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9965-9970.
15. Hungs M., Mignot E. Hypocretin/orexin, sleep and narcolepsy. Bioessays. 23:2001;397-408.
16. Kastin A.J., Banks W.A., Hahn K., Zadina J.E. Extreme stability of Tyr-MIF-1 in CSF. Neurosci. Lett. 174:1994;26-28.
17. Kastin A.J., Akerstrom V. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J. Pharmacol. Exp. Ther. 289:1999;219-223.
18. Kayama Y, Ohta M, Ito S. Ascending cholinergic and monoaminergic system in the brainstem: Do they constitute a reticular activating system? In: Nagatsu T, Fisher A, Yoshida M, editors. Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases. New York: Plenum Press, 1990. p. 683-7.
19. Kilduff T.S., Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci. 23:2000;359-365.
20. Kimura M., Kodama T., Aguila M.C., Zhang S.-Q., Inoué S. Granulocyte-macrophage colony-stimulating factor modulates rapid eye movement (REM) sleep and non-REM sleep in rats. J. Neurosci. 20:2000;5544-5551.
21. Kiyashenko L.I., Mileykovskiy B.Y., Lai Y.-Y., Siegel J.M. Increased and decreased muscle tone with orexin (hypocretin) microinjection in the locus coeruleus and pontine inhibitory area. J. Neurophysiol. 85:2001;2008-2016.
22. Kodama T. Neurotransmitters changes and REM sleep. In: Malick BN, Inoué S, editors. Rapid Eye Movement Sleep. New Delhi: Narosa Publishing House, 1999. p. 194-213.
23. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X.et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376.
24. Lubkin M., Stricker-Krongard A. Independent feeding and metabolic actions of orexins in mice. Biochem. Biophys. Res. Commun. 253:1998;241-245.
25. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M.et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435:2001;6-25.
26. Moriguchi T., Sakurai T., Nambu T., Yanagisawa M., Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci. Lett. 264:1999;101-104.
27. Nakamura T., Uramura K., Nambu T., Yada T., Goto K., Yanagisawa M.et al. Orexin-induced hyperlocomotion and stereotopy are mediated by the dopaminergic system. Brain Res. 873:2000;181-187.
28. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 355:2000;39-40.
29. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 4th Ed. New York: Academic Press, 1998.
30. Peyron C., Tighe D.K., van del Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G.et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 19:1998;9996-10015.
31. Pu S., Jain M.R., Kalra P.S., Kalra S.P. Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner. Regul. Pept. 78:1998;133-136.
32. Samson W.K., Gosnell B., Chang J.K., Resch Z.T., Murphy T.C. Cardio-vascular regulatory actions of the orexins in brain. Brain Res. 831:1999;248-253.
33. Sakurai T., Amemiya A., IshiI M., Matsuzaki I., Chemelli R.M., Tanaka H.et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
34. Siegel J.M. Narcolepsy: a key role for hypocretins. Cell. 98:1999;409-412.
35. Sunter D., Morgan I., Edwards C.M., Dakin C.L., Murphy K.G., Gardiner J.et al. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res. 907:2001;27-34.
36. Sweet D.C., Levine A.S., Billington C.J., Kotz C.M. Feeding response to central orexins. Brain Res. 821:1999;535-538.
37. Taheri S., Sunter D., Dakin C., Moyes S., Seal L., Gardiner J.et al. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci. Lett. 279:2000;109-112.
38. Takahashi N., Okumura T., Yamada H., Kohgo Y. Stimulation of gastric acids secretion by centrally administrated OX-A in conscious rats. Biochem. Biophys. Commun. 254:1999;623-627.
39. Thannical T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M.et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 27:2000;469-474.
40. Trivedi P., Yu H., MacNeil D.J., Van der Ploeg L.H.T., Guan X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438:1998;71-75.
41. Xi M., Morales F.R., Chase M.H. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the latrodorsal tegmental nucleus of the cat. Brain Res. 901:2001;259-264.
42. Yamanaka A., Tsujino N., Funahashi H., Honda K., Guan J.J., Wang Q.P.et al. Orexins activate histaminergic neurons in the tuberomammillary nucleus via the OX2 receptor. Biochem. Biophys. Res. Commun. 290:2002;1237-1245.
43. Yoshida Y., Fujiki N., Nakajima T., Ripley B., Matumura H., Yoneda H.et al. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14:2001;1075-1081.